DongKook Pharmaceutical Price To Sales vs. Debt To Equity
| 086450 Stock | KRW 16,610 30.00 0.18% |
For DongKook Pharmaceutical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of DongKook Pharmaceutical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well DongKook Pharmaceutical Co utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between DongKook Pharmaceutical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of DongKook Pharmaceutical Co over time as well as its relative position and ranking within its peers.
DongKook |
DongKook Pharmaceutical Debt To Equity vs. Price To Sales Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining DongKook Pharmaceutical's current stock value. Our valuation model uses many indicators to compare DongKook Pharmaceutical value to that of its competitors to determine the firm's financial worth. DongKook Pharmaceutical Co is number one stock in price to sales category among its peers. It is rated second in debt to equity category among its peers fabricating about 0.62 of Debt To Equity per Price To Sales. The ratio of Price To Sales to Debt To Equity for DongKook Pharmaceutical Co is roughly 1.63 . Comparative valuation analysis is a catch-all model that can be used if you cannot value DongKook Pharmaceutical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for DongKook Pharmaceutical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.DongKook Debt To Equity vs. Price To Sales
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
DongKook Pharmaceutical |
| = | 0.24 X |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
DongKook Pharmaceutical |
| = | 0.15 % |
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
DongKook Pharmaceutical Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in DongKook Pharmaceutical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, DongKook Pharmaceutical will eventually generate negative long term returns. The profitability progress is the general direction of DongKook Pharmaceutical's change in net profit over the period of time. It can combine multiple indicators of DongKook Pharmaceutical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
DongKook Pharmaceutical Co., Ltd. provides pharmaceutical products in South Korea and internationally. DongKook Pharmaceutical Co., Ltd. was founded in 1968 and is headquartered in Seoul, South Korea. DongKook Pharm is traded on Korean Securities Dealers Automated Quotations in South Korea.
DongKook Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on DongKook Pharmaceutical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of DongKook Pharmaceutical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the DongKook Pharmaceutical's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in DongKook Pharmaceutical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Technical Analysis Now
Technical AnalysisCheck basic technical indicators and analysis based on most latest market data |
| All Next | Launch Module |
Use Investing Themes to Complement your DongKook Pharmaceutical position
In addition to having DongKook Pharmaceutical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Rubber and Plastic Products Thematic Idea Now
Rubber and Plastic Products
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Rubber and Plastic Products theme has 27 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Rubber and Plastic Products Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in DongKook Stock
To fully project DongKook Pharmaceutical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of DongKook Pharmaceutical at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include DongKook Pharmaceutical's income statement, its balance sheet, and the statement of cash flows.